PYC Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
PYC Therapeutics has a total shareholder equity of A$81.1M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$91.2M and A$10.2M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$66.87m |
| Equity | AU$81.05m |
| Total liabilities | AU$10.18m |
| Total assets | AU$91.24m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: PYCDA's short term assets (A$85.6M) exceed its short term liabilities (A$9.1M).
Long Term Liabilities: PYCDA's short term assets (A$85.6M) exceed its long term liabilities (A$1.1M).
Debt to Equity History and Analysis
Debt Level: PYCDA is debt free.
Reducing Debt: PYCDA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PYCDA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PYCDA has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 33.2% each year.